Granulocyte macrophage colony-stimulating factor

Results: 45



#Item
1Cytokine may play a major role in multiple sclerosis

Cytokine may play a major role in multiple sclerosis

Add to Reading List

Source URL: medicalxpress.com

Language: English - Date: 2015-06-18 22:07:59
24-5-sup-BaumeisterVV.indd

4-5-sup-BaumeisterVV.indd

Add to Reading List

Source URL: www.glycotope.com

Language: English - Date: 2012-06-20 10:10:30
3

PDF Document

Add to Reading List

Source URL: www.2ndchance.info

Language: English - Date: 2014-02-04 17:39:26
4Ischemic postconditioning attenuates liver warm ischemia-reperfusion injury through Akt-eNOS-NO-HIF pathway

Ischemic postconditioning attenuates liver warm ischemia-reperfusion injury through Akt-eNOS-NO-HIF pathway

Add to Reading List

Source URL: www.jbiomedsci.com

Language: English
5Inflammatory factor IL-3 may play essential role in development of sepsis

Inflammatory factor IL-3 may play essential role in development of sepsis

Add to Reading List

Source URL: medicalxpress.com

Language: English - Date: 2015-05-10 22:02:05
6Mesothelioma Articles - Clinical Trial : Vaccine Therapy and ...

Mesothelioma Articles - Clinical Trial : Vaccine Therapy and ...

Add to Reading List

Source URL: www.mirg.org

Language: English - Date: 2010-10-19 13:01:08
7Table 1.1  Sites of haemopoiesis. Fetus 0–2 months (yolk sac) 2–7 months (liver, spleen) 5–9 months (bone marrow)

Table 1.1  Sites of haemopoiesis. Fetus 0–2 months (yolk sac) 2–7 months (liver, spleen) 5–9 months (bone marrow)

Add to Reading List

Source URL: www.essentialhaematology6.com

Language: English - Date: 2011-02-25 06:19:24
8October[removed]Summary of Licence Application DIR 132 Introduction An application has been made under the Gene Technology Act[removed]the Act) for dealings with a genetically modified organism (GMO), for use as a therapeuti

October[removed]Summary of Licence Application DIR 132 Introduction An application has been made under the Gene Technology Act[removed]the Act) for dealings with a genetically modified organism (GMO), for use as a therapeuti

Add to Reading List

Source URL: www.ogtr.gov.au

Language: English - Date: 2015-03-06 01:37:31
9Biotechnology / Emerging technologies / Cytokines / Growth factors / Genetically modified organism / Herpes simplex / Granulocyte macrophage colony-stimulating factor / Virus latency / Herpesviridae / Biology / Medicine / Molecular biology

October 2014 Summary of Licence Application DIR 132 Introduction An application has been made under the Gene Technology Act[removed]the Act) for dealings with a genetically modified organism (GMO), for use as a therapeutic

Add to Reading List

Source URL: www.ogtr.gov.au

Language: English - Date: 2015-03-06 01:48:49
10Statement of Principles concerning RHEUMATOID ARTHRITIS No. 68 of 2008 for the purposes of the

Statement of Principles concerning RHEUMATOID ARTHRITIS No. 68 of 2008 for the purposes of the

Add to Reading List

Source URL: www.rma.gov.au

Language: English - Date: 2013-11-10 21:38:01